CCM
LLY icon

CFO Capital Management’s Eli Lilly LLY Stock Holding History

CFO Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$715K Sell
777
-47
-6% -$47.6K 0.59% 49
2025
Q4 		$886K Buy
+824
New +$788K 0.66% 43

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

CFO Capital Management's LLY Position: Q1 2026 in Review

CFO Capital Management reduced its Eli Lilly (LLY) stake by 5.7% in Q1 2026, selling an estimated $47.6K and leaving 777 shares worth $715K. The position accounts for 0.59% of the portfolio, ranked #49.

CFO Capital Management first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $886K in Q4 2025. 4,368 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • CFO Capital Management held 777 shares of Eli Lilly worth $715K as of Q1 2026.
  • CFO Capital Management sold 47 Eli Lilly shares in Q1 2026, an estimated $47.6K.
  • Eli Lilly made up 0.59% of CFO Capital Management's portfolio in Q1 2026, its #49 holding.
  • CFO Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • CFO Capital Management's Eli Lilly position peaked at $886K in Q4 2025.
  • 4,368 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on CFO Capital Management's 13F filing for Q1 2026, filed 4 May 2026.